Innospec (NASDAQ:IOSP - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a research note issued to investors on Saturday.
Innospec Stock Performance
Shares of Innospec stock opened at $79.55 on Friday. Innospec has a 52 week low of $74.10 and a 52 week high of $128.35. The stock has a 50 day moving average price of $83.58 and a two-hundred day moving average price of $87.52. The stock has a market capitalization of $1.98 billion, a PE ratio of 101.99 and a beta of 1.11.
Innospec (NASDAQ:IOSP - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The specialty chemicals company reported $1.26 EPS for the quarter, beating analysts' consensus estimates of $1.17 by $0.09. Innospec had a return on equity of 10.89% and a net margin of 1.08%.The firm had revenue of $439.70 million during the quarter, compared to analysts' expectations of $440.70 million. During the same quarter last year, the firm posted $1.39 earnings per share. The company's revenue for the quarter was up 1.1% compared to the same quarter last year. Research analysts forecast that Innospec will post 6.18 EPS for the current year.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of the stock. State of Wyoming lifted its holdings in Innospec by 27.5% during the second quarter. State of Wyoming now owns 801 shares of the specialty chemicals company's stock worth $67,000 after acquiring an additional 173 shares during the period. California State Teachers Retirement System lifted its holdings in Innospec by 0.8% during the second quarter. California State Teachers Retirement System now owns 23,062 shares of the specialty chemicals company's stock worth $1,939,000 after acquiring an additional 179 shares during the period. Blue Trust Inc. lifted its holdings in Innospec by 38.3% during the second quarter. Blue Trust Inc. now owns 672 shares of the specialty chemicals company's stock worth $57,000 after acquiring an additional 186 shares during the period. US Bancorp DE lifted its holdings in Innospec by 4.2% during the first quarter. US Bancorp DE now owns 5,082 shares of the specialty chemicals company's stock worth $482,000 after acquiring an additional 207 shares during the period. Finally, Hsbc Holdings PLC raised its stake in shares of Innospec by 2.9% in the first quarter. Hsbc Holdings PLC now owns 7,398 shares of the specialty chemicals company's stock valued at $700,000 after buying an additional 208 shares during the period. Institutional investors own 96.64% of the company's stock.
Innospec Company Profile
(
Get Free Report)
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Innospec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.
While Innospec currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.